Augmented Intelligence Dermatology: Deep Neural Networks Empower Medical Professionals in Diagnosing Skin Cancer and Predicting Treatment Options for 134 Skin Disorders.
Adolescent
Adult
Aged
Anti-Bacterial Agents
/ therapeutic use
Antifungal Agents
/ therapeutic use
Antiviral Agents
/ therapeutic use
Clinical Competence
/ statistics & numerical data
Datasets as Topic
Deep Learning
Dermatologists
/ statistics & numerical data
Dermatology
/ methods
Dermoscopy
/ methods
Drug Therapy, Computer-Assisted
Feasibility Studies
Female
Glucocorticoids
/ therapeutic use
Humans
Image Interpretation, Computer-Assisted
Internship and Residency
/ statistics & numerical data
Male
Middle Aged
Photography
/ methods
ROC Curve
Skin
/ diagnostic imaging
Skin Diseases
/ diagnosis
Skin Neoplasms
/ diagnosis
Young Adult
Journal
The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
03
09
2019
revised:
02
12
2019
accepted:
13
01
2020
pubmed:
4
4
2020
medline:
2
4
2021
entrez:
4
4
2020
Statut:
ppublish
Résumé
Although deep learning algorithms have demonstrated expert-level performance, previous efforts were mostly binary classifications of limited disorders. We trained an algorithm with 220,680 images of 174 disorders and validated it using Edinburgh (1,300 images; 10 disorders) and SNU datasets (2,201 images; 134 disorders). The algorithm could accurately predict malignancy, suggest primary treatment options, render multi-class classification among 134 disorders, and improve the performance of medical professionals. The area under the curves for malignancy detection were 0.928 ± 0.002 (Edinburgh) and 0.937 ± 0.004 (SNU). The area under the curves of primary treatment suggestion (SNU) were 0.828 ± 0.012, 0.885 ± 0.006, 0.885 ± 0.006, and 0.918 ± 0.006 for steroids, antibiotics, antivirals, and antifungals, respectively. For multi-class classification, the mean top-1 and top-5 accuracies were 56.7 ± 1.6% and 92.0 ± 1.1% (Edinburgh) and 44.8 ± 1.2% and 78.1 ± 0.3% (SNU), respectively. With the assistance of our algorithm, the sensitivity and specificity of 47 clinicians (21 dermatologists and 26 dermatology residents) for malignancy prediction (SNU; 240 images) were improved by 12.1% (P < 0.0001) and 1.1% (P < 0.0001), respectively. The malignancy prediction sensitivity of 23 non-medical professionals was significantly increased by 83.8% (P < 0.0001). The top-1 and top-3 accuracies of four doctors in the multi-class classification of 134 diseases (SNU; 2,201 images) were increased by 7.0% (P = 0.045) and 10.1% (P = 0.0020), respectively. The results suggest that our algorithm may serve as augmented intelligence that can empower medical professionals in diagnostic dermatology.
Identifiants
pubmed: 32243882
pii: S0022-202X(20)30136-6
doi: 10.1016/j.jid.2020.01.019
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Antifungal Agents
0
Antiviral Agents
0
Glucocorticoids
0
Banques de données
figshare
['10.6084/m9.figshare.6454973']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1753-1761Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.